hg-9-91-01 and 2-4-diaminopyrimidine

hg-9-91-01 has been researched along with 2-4-diaminopyrimidine* in 1 studies

Other Studies

1 other study(ies) available for hg-9-91-01 and 2-4-diaminopyrimidine

ArticleYear
The use of salt-inducible kinase inhibitors to treat autoimmune and inflammatory diseases: evaluation of WO2013136070.
    Expert opinion on therapeutic patents, 2014, Volume: 24, Issue:8

    Novel methods for the treatment of inflammatory and autoimmune diseases comprising the administration of salt-inducible kinase inhibitors are claimed. One novel inhibitor (HG-9-91-01) and the use of 2,4-diaminopyrimidine and 2,6-diaminopyrimidine derivatives are claimed. The use of such inhibitors upregulates the level of the anti-inflammatory cytokine IL-10 in macrophages.

    Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Drug Design; Enzyme Inhibitors; Humans; Inflammation; Interleukin-10; Macrophages; Patents as Topic; Phenylurea Compounds; Protein Serine-Threonine Kinases; Pyrimidines

2014